[1] MaherS , ToomeyD , CondronC , etal.Activation-inducedcelldeath:thecontroversialroleofFasandFasligandinimmuneprivilegeandtumourcounterattack[J].ImmunolCellBiol, 2002, 80 (2) ∶131-7.
|
[2] NakamuraK , YuhK , SugyoS , etal.ApoptosisobservedinperipheralTlymphocytesfrompatientswithchronichepatitisB[J].Gastroenterology.1996, 111 (1) ∶156-64.
|
[3] AbbasAK , MurphyKM , SherA , etal.FunctionaldiversityofhelperTlymphocytes[J]Nature, 1996, 383 (6603) ∶787-93.
|
[4] DelPreteG , MaggiE , RomagnaniS , etal.HumanTh1andTh2cells:functionalproperties, mechanismsofregulation, androleindisease[J].LabInvest, 1994, 70 (3) ∶299-306.
|
[5] HalickaDH , PozarowskiP , ItaM , etal.Enhancementofactivation-inducedapoptosisoflymphocytesbythecytotoxicribonucleaseonconase (Ranpirnase) [J].IntJOncol, 2002, 21 (6) ∶1245-50.
|
[6] FukudaR , IshimuraN , NguyenTX , etal.TheexpressionofIL -2, IL-4andinterferon-gamma (IFN -gamma) mRNA/usingliverbiopsiesatdifferentphasesofacuteexacerbationofchronichepatitisB[J].ClinExpImmunol, 1995, 100 (3) ∶446-51.
|
[7] HsuHY , ChangMH , NiYH , etal.CytokinereleaseofperipheralbloodmononuclearcellsinchildrenwithchronichepatitisBvirusinfection[J].JPediatrGastroenterolNutr, 1999, 29 (5) ∶540-5.
|
[8] PriimiagiLS , TefanovaVT , TalloTG , etal.〔Th1-cytokinesinchronichepatitisBandC〕[J].VoprVirusol, 2002, 47 (3) ∶23-7.
|
[9]邢同京, 章廉, 骆抗先, 等.Th1/Th2类细胞因子对慢性乙型肝炎患者淋巴细胞凋亡的影响[J].解放军医学杂志, 2000, 25 (1) ∶16-18.
|
[10] SchlaakJF , TullyG , LohrHF , etal.ThepresenceofhighamountsofHBV -DNAinserumisassociatedwithsuppressedcostimulatoryeffectsofinterleukin-12onHBV -inducedimmuneresponse[J].Hepatol, 1999, 30 (3) ∶353-8.
|
[1] | Lingling ZHU, Yani ZHANG, Tingting SHI, Yang WU, Chun GAO, Xiaohui YU, Yujing HE, Jiucong ZHANG. The role of tumor necrosis factor-α in the development and progression of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2024, 40(11): 2320-2325. doi: 10.12449/JCH241129 |
[2] | Wen QIN, Jianyu YANG, Taiwen CHEN, Haiping ZHENG, Xiaodong ZHU. Expression and significance of L1 cell adhesion molecule and transforming growth factor-β1 in pancreatic cancer tissue[J]. Journal of Clinical Hepatology, 2021, 37(6): 1404-1408. doi: 10.3969/j.issn.1001-5256.2021.06.035 |
[3] | YUSUFUKADIER·Maimaitinijiati, AIMAITI·Yasen, Li WenDing, Ran Bo, TUERGANAILI.aji, Shao YingMei, Wen Hao. Effect of the transforming growth factor-β1 signaling pathway in inducing the differentiation of hepatic progenitor cells[J]. Journal of Clinical Hepatology, 2020, 36(3): 620-623. doi: 10.3969/j.issn.1001-5256.2020.03.030 |
[4] | Mo XiaoLi, Liu Jie, Zhu JiaYu, Chen Chuang, Ou Jie, Mao SuFei. Value of transforming growth factor-β1 in diagnosis of primary liver cancer:a meta-analysis[J]. Journal of Clinical Hepatology, 2017, 33(5): 864-868. doi: 10.3969/j.issn.1001-5256.2017.05.014 |
[5] | An BaiQuan, Xin YongNing, Lu LinLin, Xuan ShiYing. Effect of PNPLA3 I148M mutation on expression of TGF- β1 in rat hepatic stellate cells[J]. Journal of Clinical Hepatology, 2016, 32(4): 769-771. doi: 10.3969/j.issn.1001-5256.2016.04.035 |
[6] | Chi ZhaoChun, Geng ZhangXin. Application of tumor necrosis factor antagonists in hepatic disease treatment[J]. Journal of Clinical Hepatology, 2015, 31(7): 1176-1179. doi: 10.3969/j.issn.1001-5256.2015.07.045 |
[7] | Gao HuiXia, Liu YuZhen, Lu JianHua, Ye LiHong, Dai ErHei. Correlation of Foxp3 + Tregs and TGFβ1 expression with inflammation in livers of patients with primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(12): 952-955. |
[9] | Kang HaiYan, Dong JiangLong, Wang JianBin, Li BingShun, Zhang HongXia. Relationship between transforming growth factor β1 and liver fibrosis and liver function in 260 patients with hepatitis B [J]. Journal of Clinical Hepatology, 2009, 25(1): 61-62. |
[10] | Zhan GuoQing, Zheng SanJu, Zhu Lin, Li JinKe, Hu Bo, Xie XingRong. Protective effect of tiopionin on liver injury caused by transcatheter arterial chemoembolization in liver carcinoma.[J]. Journal of Clinical Hepatology, 2009, 25(1): 48-50. |
[11] | Xu TingTing, Jiang MiaoNa, Jia YuJie, Che Ying. Ganfukang's effect on transforming growth factor β1 and laminin of experimental liver fibrosis rats[J]. Journal of Clinical Hepatology, 2005, 21(1): 30-31. |
[12] | Ling YunFeng, Feng ZhenBo, He RuKun, Lu: ZiLi. Expression of TGFβ1、TGFβRⅠ and TGFβRⅡ in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2005, 21(1): 35-37. |
[13] | Bi Qing, Cheng Lei, Cui LiAn, Zhang JunFu. The effect of Kangxianruanjian on TGF β1 and it's the recepters in liver fibrosis in rats[J]. Journal of Clinical Hepatology, 2002, 18(3): 181-182. |
[15] | Zhu YingHua, Song HongLi, Zhang Yi, Yu Guang, Han JiJin. The Clinieal study about interleukin-1 and tumor necrosis factor Alpha in hepatocirrhosis[J]. Journal of Clinical Hepatology, 2001, 17(4): 233-234. |
[16] | Li QingHua, Li Hui, Qin ChengYong, Han GuoQing. The significance of urine transforming growth factor-β1 (TGF-β1) and serum procollagen type Ⅲ (PCⅢ) , collagen type Ⅳ (Ⅳ-C) , hyaluronic (HA) and laminin (LN) in patient with chronic HBV related liver disease[J]. Journal of Clinical Hepatology, 2001, 17(3): 161-162. |
[17] | Zhang Min, Zhang LingXia, Xin ShaoJie, Zhao JingMin, Wang SongShan, Wang LinJie. The relationship between transforming growth factor β1 and liver fibrosis[J]. Journal of Clinical Hepatology, 2000, 16(1): 32-33. |